Mr. Wheeler joined Patheon as Chief Executive Officer in December 2007. Mr. Wheeler’s 29-year career includes multinational experience in pharmaceutical manufacturing, sales and marketing, R&D and engineering with three global pharmaceutical companies. He joined Patheon from Valeant Pharmaceuticals International, a California-based global specialty pharmaceutical company, where he served most recently as President, North America, R&D and Global Manufacturing. Prior to joining Valeant in 2003, Mr. Wheeler served as President and Chief Executive Officer of DSM Pharmaceuticals Inc., a contract pharmaceutical manufacturer, where he led the organization through a business turnaround, significantly increasing new business, compliance and profitability. Prior to DSM, Mr. Wheeler was Senior Vice-President of Logistics and Strategy for GlaxoSmithKline plc, where he managed the manufacturing rationalization of Glaxo Wellcome and SmithKline Beecham, which included a supply network of over 100 plants in 41 countries. Previous to his manufacturing role, Mr. Wheeler was Vice President of Marketing for Glaxo Wellcome, where he was responsible for antibiotic, antiviral, gastrointestinal and metabolic products, and was instrumental in developing the marketing services infrastructure. Mr. Wheeler joined Glaxo in 1989 after a 12-year career at Exxon Research & Engineering Co. Mr. Wheeler holds a bachelor of science degree in mechanical engineering from Worcester Polytechnic Institute and a master of business administration degree from California Lutheran University.

Eric W. Evans
Chief Financial Officer & Executive Vice President

Mr. Evans joined Patheon in May 2008, bringing over 24 years of experience in various financial leadership roles in the pharmaceutical, steel, energy and financial services industries. Prior to joining Patheon he held progressively senior finance positions, including Vice President, Financial Services at Novartis. Prior to that Mr. Evans served as the Chief Financial Officer of Sandoz. He holds a Bachelor of Arts degree from Queens University and a Graduate degree from the University of Western Ontario. Additionally, Mr. Evans earned a Masters of Business Administration degree from Case Western Reserve University in Cleveland, Ohio.

Peter T. Bigelow
President, North American
Operations

Peter T. Bigelow is the President, North American Operations at Patheon.  Peter brings nearly 30 years of technical operating and engineering experience to Patheon.  Mr. Bigelow most recently served as Senior Vice President at Wyeth Pharmaceuticals, where he had responsibility for Wyeth’s global consumer healthcare product manufacturing and oversight of Wyeth’s operations in Latin America. Peter joined Wyeth in 1995 and in his 14 years had several executive posts spanning the breadth of pharmaceutical manufacturing and technical operations.  Prior to joining Wyeth, Peter spent 13 years with SmithKline Beecham (now GlaxoSmithKline) in a variety of engineering and operations roles.  He holds a BS in Mechanical Engineering from Villanova University and an MBA from Philadelphia University.

Mr. Garofolo serves as Executive Vice President of Engineering, Procurement, Patheon Advantage, and Information Technology. Mr. Garofolo joined Patheon in May 2008, bringing more than 14 years of information and management consulting leadership experience. Most recently, he served as Chief Information Officer at Valeant Pharmaceuticals where he was responsible for all aspects of the global IT organization including the implementation of a series of new applications and processes including; SAP, LiveLink (EDMS), and SQL*LIMS. Prior to that, Mr. Garofolo was the Chief Technology Officer for Broadlane, the fourth largest Group Purchasing Organization within the U.S. Healthcare market. He also worked in the management consulting industry for both Ernst & Young and Oracle. Mr. Garofolo holds a BSBA from the University of Arizona with a concentration in Management Information Systems.

Geoffrey M. Glass is the Executive Vice President of Global Strategy, Sales and Marketing at Patheon.  Mr. Glass is a member of the Executive Management team and leads the company’s Strategy, as well all Sales, Marketing and Corporate Development initiatives world-wide.
Previously, he spent almost five years on the Executive Team at Valeant Pharmaceuticals.
At Valeant Mr. Glass was the Senior Vice President of Asian Operations at Valeant Pharmaceuticals where he had responsibilities for all of Valeant's business affairs in the region which included over 250 products in 14 countries. 
Prior to leading the Asian business for Valeant Geoff was Senior Vice President and Chief Information Officer of Valeant Pharmaceuticals International.  In this role, Mr. Glass was responsible for all information technology-related matters for the company.
Prior to joining Valeant, Mr. Glass was the Global Leader of Life Sciences Operations Excellence Practice for Cap Gemini (formerly Ernst & Young LLP Consulting). During his tenure at Cap Gemini, Mr. Glass led global teams through the successful implementation of business and IT transformations at a number of leading life sciences organizations.
Mr. Glass earned his bachelor of arts in Economics and Political Science at the University of Arizona.

Ms. Fathallah joined Patheon in May 2008. Most recently, she served as Vice President, General Counsel – Europe, Middle East & Africa (“EMEA”) region for Valeant Pharmaceuticals International. In this capacity, she oversaw the legal affairs of Valeant’s 14 national subsidiaries and 6 branch offices in the EMEA region. Ms. Fathallah was also responsible for the legal affairs of Valeant’s Research & Development division. In addition to her pharmaceutical experience she has extensive experience in all aspects of corporate and business law gained from her time in private practice at law firms including Paul, Hastings, Janofsky & Walker LLP as well as Foley & Lardner LLP. She holds a Bachelor of Science degree in Business Administration from the University of Southern California and has studied International and Comparative Law at the University of Oxford in England. Ms. Fathallah received her Juris Doctorate degree from the University of Southern California Law Center, is a member of the California State Bar and the American Bar Association.

Doug Mendenhall
Interim Head, Pharmaceutical Development Services & Chief Scientific Officer

Doug joined Patheon in June 2009 as Interim Head, Pharmaceutical Development Services and Chief Scientific Officer. Doug is a 35 year veteran of the pharmaceutical industry, holding senior executive positions at Abbott, Glaxo/GlaxoWellcome/GlaxoSmithKline and, most recently, Merck. He has spent his career leading pharmaceutical and pre-clinical development organizations and has a track record of developing and bringing to market a very large and impressive list of blockbuster products for three large pharmaceutical companies. Doug holds a Ph.D. in Pharmaceutical Chemistry and a Masters in Medicinal Chemistry from the University of Kansas and a bachelors in Pharmacy from the University of Washington. He is also a graduate of the Northwestern University/Kellogg School of Management Executive Development Program and is Lean Six-Sigma certified.

Andrew Kelley
Senior Vice President, Commercial Operations, Europe and Asia Pacific

Antonella Mancuso
Sr VP  & Managing Director, European Operations

Mr. Kelley joined Patheon in January 2006 as Vice President of Operations for the UK. He progressed to the position of Vice President of Operations for the UK and France and now holds the position of Senior Vice President of Commercial Operations for Europe and Asia Pacific and brings to his role more than 24 years of experience in pharmaceutical operations. Mr. Kelley joined Patheon from Cardinal Health, where he spent 15 years in progressively senior production and operational roles, lastly serving as Vice President, Operations for Europe and Site Leader for Swindon. In this position, he was responsible for operations at Cardinal’s site in Swindon, as well as 10 other facilities in the U.K., Germany, France, Italy and Belgium. Prior to Cardinal, he held manufacturing management roles at Boehringer Ingelheim and at Roussel Laboratories. He began his career as a Process and Technical Services Engineer at Esso Chemicals Ltd. Mr. Kelley holds a Bachelor of Science degree in Chemical Engineering from the University of Birmingham and a Master of Business Administration from Henley Management College in Oxfordshire, U.K.

Ms. Mancuso joined Patheon in 2001 as Production Manager of Patheon’s facility in Monza, Italy, becoming Site Director in June 2002.  She became Director, Italian Operations in January 2005, with responsibility for integrating and managing both the Monza and Ferentino sites.  In February 2009, Ms. Mancuso was appointed to her current position of  Senior Vice President & Managing Director, European Operations.  In this role, she will be responsible for managing all European commercial manufacturing sites and the business associated with these sites. Antonella is also a member of the Patheon Executive Management Committee.  Prior to joining Patheon, Ms. Mancuso held progressively senior roles in production and manufacturing during her six years at Bristol-Myers Squibb (BMS) in Italy.  Prior to BMS, Antonella served as Qualified Technical Director with Select Pharma.  She began her career in 1991 at Bioprogress in Rome, where her responsibilities included quality control and registration of pharmaceutical products.   Antonella holds a Degree in Pharmaceutical Chemistry and Technology from La Sapienza University of Rome.

Warren A. Horton
Vice-President Global Quality Operations

Mr. Horton serves as Vice President of Quality Assurance, Environmental Health & Safety, and Regulatory. Mr. Horton joined Patheon in May 2008, bringing more than 25 years of pharmaceutical industry experience in the area of Quality. Most recently at DSM in Greenville, North Carolina, he was Vice President Quality Assurance and Regulatory Affairs. Prior to that Mr. Horton spend approximately 10 years at Abbott Laboratories in a variety of Production and Quality Assurance roles covering a full range of dosage form types. Mr. Horton is a graduate of Southeast Missouri State University.